Comparison of standard- and nano-flow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins

Analytical and Bioanalytical Chemistry

Volumn 404, Issue 4, 2012, Pages 1089-1101

  Percy, Andrew J ^a   Chambers, Andrew G ^a   Yang, Juncong ^a   Domanski, Dominik ^a   Borchers, Christoph H ^a,b  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF VICTORIA   (Canada)

Author keywords

Multiple reaction monitoring; Nano flow; Plasma; Quantitative proteomics; Stable isotope labeling; Standard flow

Indexed keywords

MULTIPLE REACTION MONITORING; NANO-FLOW; QUANTITATIVE PROTEOMICS; STABLE-ISOTOPE LABELING; STANDARD-FLOW;

CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPES; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PEPTIDES; PLASMAS;

LOADING;

PEPTIDE; PLASMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHEMISTRY; COMPARATIVE STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSTRUMENTATION; MALE; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PEPTIDES; YOUNG ADULT;

EID: 84865584319     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-012-6010-y     Document Type: Article

References (34)

1. GL Hortin D Sviridov NL Anderson 2008 High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance Clin Chem 54 1608 1616 10.1373/clinchem.2008.108175 1:CAS:528:DC%2BD1cXht1CiurbN
2. SF Kingsmore 2006 Multiplexed protein measurement: technologies and applications of protein and antibody arrays Nat Rev Drug Discov 5 310 320 10.1038/nrd2006 1:CAS:528:DC%2BD28XjtVaksr8%3D
3. TA Addona SE Abbatiello B Schilling SJ Skates DR Mani DM Bunk CH Spiegelman LJ Zimmerman A-JL Ham H Keshishian SC Hall S Allen RK Blackman CH Borchers C Buck HL Cardasis MP Cusack NG Dodder BW Gibson JM Held T Hiltke A Jackson EB Johansen CR Kinsinger J Li M Mesri TA Neubert RK Niles TC Pulsipher D Ransohoff H Rodriguez PA Rudnick D Smith DL Tabb TJ Tegeler AM Variyath LJ Vega-Montoto A Wahlander S Waldemarson M Wang JR Whiteaker L Zhao NL Anderson SJ Fisher DC Liebler AG Paulovich FE Regnier P Tempst SA Carr 2009 Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma Nat Biotechnol 27 7 633 641 10.1038/nbt.1546 1:CAS:528:DC%2BD1MXnslKqurY%3D
4. H Keshishian T Addona M Burgess E Kuhn SA Carr 2007 Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics 6 2212 2229 10.1074/mcp.M700354-MCP200 1:CAS:528:DC%2BD1cXksF2hsw%3D%3D
5. CE Parker TW Pearson NL Anderson CH Borchers 2010 Mass-spectrometry-based clinical proteomics- A review and prospective Analyst 135 1830 1838 10.1039/c0an00105h 1:CAS:528:DC%2BC3cXovFygu7k%3D
6. R Huttenhain J Malmstrom P Picotti R Aebersold 2009 Perspectives of targeted mass spectrometry for protein biomarker verification Curr Opin Chem Biol 13 5-6 518 525 10.1016/j.cbpa.2009.09.014
7. L Anderson 2005 Candidate-based proteomics in the search for biomarkers of cardiovascular disease J Physiol 563 23 60 10.1113/jphysiol.2004.080473 1:CAS:528:DC%2BD2MXitVSntLk%3D
8. Chen Y-T, Chen H-W, Domanski D, Smith DS, Liang K-H, Wu C-C, Chen C-L, Chung T, Chen M-C, Chang Y-S, Parker CE, Borchers CH, Yu J-S (2012) Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. Proteomics. doi: 10.1016/j.jprot.2011.12.031
9. MA Kuzyk D Smith J Yang TJ Cross AM Jackson DB Hardie NL Anderson CH Borchers 2009 Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma Mol Cell Proteomics 8 8 1860 1877 10.1074/mcp.M800540-MCP200 1:CAS:528:DC%2BD1MXhtVSjtbjM
10. T Fortin A Salvador JP Charrier C Lenz X Lacoux A Morla G Choquet-Kastylevsky J Lemoine 2009 Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests Mol Cell Proteomics 8 1006 1015 10.1074/mcp.M800238-MCP200 1:CAS:528:DC%2BD1MXmtlGqtLc%3D
11. H Keshishian T Addona M Burgess DR Mani X Shi E Kuhn MS Sabatine RE Gerszten SA Carr 2009 Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution Mol Cell Proteomics 8 2339 2349 10.1074/mcp.M900140-MCP200 1:CAS:528:DC%2BD1MXht12qs7%2FL
12. JR Whiteaker L Zhao L Anderson AG Paulovich 2010 An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers Mol Cell Proteomics 9 184 196 10.1074/mcp.M900254-MCP200 1:CAS:528:DC%2BC3cXjtFWhs7Y%3D
13. E Kuhn J Wu J Karl H Liao W Zolg B Guild 2004 Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards Proteomics 4 1175 1186 10.1002/pmic.200300670 1:CAS:528:DC%2BD2cXjt1Smtb8%3D
14. N Zolotarjova P Mrozinski H Chen J Martosella 2008 Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum J Chromatogr A 1189 332 338 10.1016/j.chroma.2007.11.082 1:CAS:528:DC%2BD1cXkvFGmsL0%3D
15. H Liao J Wu E Kuhn W Chin B Chang MD Jones S O'Neil KR Clauser J Karl F Hasler R Roubenoff W Zolg BC Guild 2004 Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis Arthritis Rheum 50 12 3792 3803 10.1002/art.20720 1:CAS:528:DC%2BD2MXls1ehtA%3D%3D
16. GR Nicol M Han J Kim CE Birse E Brand A Nguyen M Mesri W FitzHugh P Kaminker PA Moore SM Ruben T He 2008 Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients Mol Cell Proteomics 7 1974 1982 10.1074/mcp.M700476-MCP200 1:CAS:528:DC%2BD1cXht1Ols7zJ
17. L Anderson CL Hunter 2006 Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins Mol Cell Proteomics 5 4 573 588 1:CAS:528:DC%2BD28XjsVCmtb8%3D
18. S Lin TA Shaler CH Becker 2006 Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap Anal Chem 78 5762 5767 10.1021/ac060613f 1:CAS:528:DC%2BD28XmvVGhsLc%3D
19. SA Agger LC Marney AN Hoofnagle 2010 Simultaneous quantification of apolipoprotein a-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry Clin Chem 56 12 1804 1813 10.1373/clinchem.2010.152264 1:CAS:528:DC%2BC3cXhsF2js7%2FK
20. Domanski D, Percy AJ, Yang J, Chambers AG, Hill JS, Cohen Freue GV, Borchers CH (2012) MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics. doi: 10.1002/pmic.201100568
21. M Berna B Ackermann 2009 Increased throughput for low-abundance protein biomarker verification by liquid chromatography/tandem mass spectrometry Anal Chem 81 3950 3956 10.1021/ac9002744 1:CAS:528:DC%2BD1MXkvFertbc%3D
22. JR Whiteaker H Zhang JK Eng R Fang BD Piening L-C Feng TD Lorentzen RM Schoenherr JF Keane T Holzman M Fitzgibbon C Lin H Zhang K Cooke T Liu DG Camp II L Anderson J Watts RD Smith MW McIntosh AG Paulovich 2007 Head-to-head comparison of serum fractionation techniques J Proteome Res 6 2 828 836 10.1021/pr0604920 1:CAS:528:DC%2BD28XhtlCit73E
23. D Domanski DS Smith CA Miller Y Yang AM Jackson G Cohen Freue JS Hill CE Parker CH Borchers 2011 High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment Clin Lab Med 31 3 371 384 10.1016/j.cll.2011.07.005
24. M Wilm M Mann 1996 Analytical properties of the nanoelectrospray ion source Anal Chem 68 1 8 10.1021/ac9509519 1:CAS:528:DyaK2MXpslSru7k%3D
25. M Wilm A Shevchenko T Houthaeve S Breit L Schweigerer T Fotsis M Mann 1996 Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry Nature 379 6564 466 469 10.1038/379466a0 1:CAS:528:DyaK28XovVagug%3D%3D
26. JL Proc MA Kuzyk DB Hardie J Yang DS Smith AM Jackson CE Parker CH Borchers 2010 A quantitative study of the effects of chaotropic agents, surfactants, and solvents on the digestion efficiency of human plasma proteins by trypsin J Proteome Res 9 10 5422 5437 10.1021/pr100656u 1:CAS:528: DC%2BC3cXhtFGru7bN
27. Kuzyk MA, Parker CE, Borchers CH (2012, in press) Development of MRM based assays for plasma proteins. In: Backvall H (ed) Methods in molecular biology. Humana Press, Totowa
28. DL Tabb Y Huang VH Wysocki JR Yates 3rd 2004 Influence of basic residue content on fragment ion peak intensities in low-energy collision-induced dissociation spectra of peptides Anal Chem 76 5 1243 1248 10.1021/ac0351163 1:CAS:528:DC%2BD2cXls1WhsQ%3D%3D
29. N Rifai MA Gillette SA Carr 2006 Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nat Biotechnol 24 8 971 983 10.1038/nbt1235 1:CAS:528:DC%2BD28XnvVygtL8%3D
30. V Lange P Picotti B Domon R Aebersold 2008 Selected reaction monitoring for quantitative proteomics: a tutorial Mol Syst Biol 4 222 10.1038/msb.2008.61
31. AM Mirza S Ezzat AA Axelrad 1997 Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro Blood 89 1862 1869 1:CAS:528: DyaK2sXhvVakurY%3D
32. JP Miletich GJJ Broze 1987 Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy Blood 69 6 1580 1586 1:CAS:528:DyaL2sXktlaqsbY%3D
33. SA Gerber J Rush O Stemman MW Kirschner SP Gygi 2003 Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS Proc Natl Acad Sci USA 100 12 6940 6945 10.1073/pnas.0832254100 1:CAS:528:DC%2BD3sXkslOnt7Y%3D
34. US Food and Drug Administration (1999) Draft guidance for industry: bioanalytical method validation. US Food and Drug Administration, Rockville